onsdag 31. mai 2017

China’s Ill, and Wealthy, Look Abroad for Medical Treatment

China’s medical system could not stop the cancer eating at Guo Shushi’s stomach. It roared back even after Mr. Guo, a 63-year-old real estate developer, endured surgery, chemotherapy and radiation at two hospitals. Then his son-in-law discovered online that — for a price — companies were willing to help critically ill Chinese people seek treatment abroad. Soon Mr. Guo was at the Dana-Farber Cancer Institute in Boston, receiving a new immunotherapy drug, Keytruda, which is not available in China. In April, nearly four months later, his tumor has shrunk and his weight has gone up. “When I arrived, I could feel how large the gap was,” said Mr. Guo of the difference in care. The cost: about $220,000 — all paid out of pocket. Read more